Olivet, France

Nathalie Lamerant-Fayel


 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nathalie Lamerant-Fayel: Innovator in Stem Cell Research

Introduction

Nathalie Lamerant-Fayel is a prominent inventor based in Olivet, France. She has made significant contributions to the field of stem cell research, particularly in the development of endothelial cell precursors. With a total of 2 patents, her work has implications in both medical and veterinary fields.

Latest Patents

Lamerant-Fayel's latest patents include "Human and murine stem-cell lines: models of endothelial cell precursors." This invention relates to isolated human and murine cells that serve as precursors to endothelial cells, excluding embryonic stem cells. The established cell lines can be utilized in therapeutic applications and studies of cellular mechanisms. Another notable patent is "Organ-specific feline endothelial cells and uses thereof," which focuses on isolated organ-specific feline endothelial cells. This invention also encompasses methods for screening molecules and studying various pathologies.

Career Highlights

Throughout her career, Nathalie Lamerant-Fayel has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Ludwick Hirszfeld Institute of Immunology and Experimental Therapy at the Polish Academy. Her research has been pivotal in advancing our understanding of endothelial cells and their applications.

Collaborations

Lamerant-Fayel has collaborated with notable colleagues, including Claudine Kieda and Maria Paprocka. These partnerships have further enriched her research and contributed to the scientific community.

Conclusion

Nathalie Lamerant-Fayel is a distinguished inventor whose work in stem cell research has opened new avenues for medical and veterinary applications. Her innovative patents reflect her commitment to advancing science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…